Other Species / Isoforms
  SSH1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T5-p
___MALVtLQRsPtP
0 1
SSH1 (human) ___MALVtLQRsPtP T5-p
SSH1 iso2 (human) ___MALVTLQRSPTP T5
SSH1 iso4 (human) gap -
SSH1 (mouse) ___MALVTLQRSPTP T5
SSH1 (rat) ___MDLFFLSDFCVF F5
S9-p
ALVtLQRsPtPSAAS
0 2
SSH1 (human) ALVtLQRsPtPSAAS S9-p
SSH1 iso2 (human) ALVTLQRSPTPSAAS S9
SSH1 iso4 (human) gap -
SSH1 (mouse) ALVTLQRSPTPSAAS S9
SSH1 (rat) SDFCVFLRPTRYLCH R14
T11-p
VtLQRsPtPSAASSS
0 1
SSH1 (human) VtLQRsPtPSAASSS T11-p
SSH1 iso2 (human) VTLQRSPTPSAASSS T11
SSH1 iso4 (human) gap -
SSH1 (mouse) VTLQRSPTPSAASSS T11
SSH1 (rat) FCVFLRPTRYLCHSG T16
S22
ASSSASNSELEAGSE
0 1
SSH1 (human) ASSSASNSELEAGSE S22
SSH1 iso2 (human) ASSSASNSELEAGSE S22
SSH1 iso4 (human) gap -
SSH1 (mouse) ASSSASNsELEAGsD S22-p
SSH1 (rat) gap -
S28
NSELEAGSEEDRKLN
0 2
SSH1 (human) NSELEAGSEEDRKLN S28
SSH1 iso2 (human) NSELEAGSEEDRKLN S28
SSH1 iso4 (human) gap -
SSH1 (mouse) NsELEAGsDEERKLN S28-p
SSH1 (rat) gap -
S37-p
EDRKLNLsLSESFFM
0 1
SSH1 (human) EDRKLNLsLSESFFM S37-p
SSH1 iso2 (human) EDRKLNLSLSESFFM S37
SSH1 iso4 (human) gap -
SSH1 (mouse) EERKLNLSLSESFFM S37
SSH1 (rat) SGVSSPRYLSESFFM Y29
S57-p
LFLQQGSsPQGQRSL
Upstream
0 6
Treatment
  • nocodazole
SSH1 (human) LFLQQGSsPQGQRSL S57-p
SSH1 iso2 (human) LFLQQGSSPQGQRSL S57
SSH1 iso4 (human) gap -
SSH1 (mouse) LFLQQGNsPQGQRSL S57-p
SSH1 (rat) LFLQQGNSPQGQRSL S49
S261-p
LIKAKLRsIMMSQDL
0 1
SSH1 (human) LIKAKLRsIMMSQDL S261-p
SSH1 iso2 (human) LIKAKLRSIMMSQDL S261
SSH1 iso4 (human) gap -
SSH1 (mouse) LIKAKLRSIMMSQDL S261
SSH1 (rat) LIKAKLRSIMMSQDL S253
K274
DLENVTSKEIRNELE
0 1
SSH1 (human) DLENVTSKEIRNELE K274
SSH1 iso2 (human) DLENVTSKEIRNELE K274
SSH1 iso4 (human) gap -
SSH1 (mouse) DLENVTSkEIRNELE K274-ac
SSH1 (rat) DLENVTSKEIRNELE K266
S325
LGSEWNASNLEELQG
0 1
SSH1 (human) LGSEWNASNLEELQG S325
SSH1 iso2 (human) LGSEWNASNLEELQG S325
SSH1 iso4 (human) gap -
SSH1 (mouse) LGSEWNAsNLEELQG S325-p
SSH1 (rat) LGSEWNASNLEELQG S317
S402-p
MGVSRSAstVIAYAM
Upstream
Downstream
2 8
Effects on Modified Protein
  • enzymatic activity, inhibited
  • molecular association, regulation
Effects on Biological Processes:
  • cell motility, altered
Kinase, in vitro:
  • PRKD1 (human)
SSH1 (human) MGVSRSAstVIAYAM S402-p
SSH1 iso2 (human) MGVSRSASTVIAYAM S402
SSH1 iso4 (human) MGVSRSASTVIAYAM S90
SSH1 (mouse) MGVSRSASTVIAYAM S402
SSH1 (rat) MGVSRSASTVIAYAM S394
T403-p
GVSRSAstVIAYAMK
0 5
SSH1 (human) GVSRSAstVIAYAMK T403-p
SSH1 iso2 (human) GVSRSASTVIAYAMK T403
SSH1 iso4 (human) GVSRSASTVIAYAMK T91
SSH1 (mouse) GVSRSASTVIAYAMK T403
SSH1 (rat) GVSRSASTVIAYAMK T395
S428-p
NYVKQKRsItRPNAG
0 1
SSH1 (human) NYVKQKRsItRPNAG S428-p
SSH1 iso2 (human) NYVKQKRSITRPNAG S428
SSH1 iso4 (human) NYVKQKRSITRPNAG S116
SSH1 (mouse) NYVKQKRSITRPNAG S428
SSH1 (rat) NYVKQKRSITRPNAG S420
T430-p
VKQKRsItRPNAGFM
0 1
SSH1 (human) VKQKRsItRPNAGFM T430-p
SSH1 iso2 (human) VKQKRSITRPNAGFM T430
SSH1 iso4 (human) VKQKRSITRPNAGFM T118
SSH1 (mouse) VKQKRSITRPNAGFM T430
SSH1 (rat) VKQKRSITRPNAGFM T422
S441-p
AGFMRQLsEyEGILD
0 4
SSH1 (human) AGFMRQLsEyEGILD S441-p
SSH1 iso2 (human) AGFMRQLSEYEGILD S441
SSH1 iso4 (human) AGFMRQLSEYEGILD S129
SSH1 (mouse) AGFMRQLSEYEGILD S441
SSH1 (rat) AGFMRQLSEYEGILD S433
Y443-p
FMRQLsEyEGILDAS
0 1
SSH1 (human) FMRQLsEyEGILDAS Y443-p
SSH1 iso2 (human) FMRQLSEYEGILDAS Y443
SSH1 iso4 (human) FMRQLSEYEGILDAS Y131
SSH1 (mouse) FMRQLSEYEGILDAS Y443
SSH1 (rat) FMRQLSEYEGILDAS Y435
T462-p
NKLWRQQtDssLQQP
0 2
SSH1 (human) NKLWRQQtDssLQQP T462-p
SSH1 iso2 (human) NKLWRQQTDSSLQQP T462
SSH1 iso4 (human) NKLWRQQTDSSLQQP T150
SSH1 (mouse) gap -
SSH1 (rat) gap -
S464-p
LWRQQtDssLQQPVD
0 2
SSH1 (human) LWRQQtDssLQQPVD S464-p
SSH1 iso2 (human) LWRQQTDSSLQQPVD S464
SSH1 iso4 (human) LWRQQTDSSLQQPVD S152
SSH1 (mouse) gap -
SSH1 (rat) gap -
S465-p
WRQQtDssLQQPVDD
0 2
SSH1 (human) WRQQtDssLQQPVDD S465-p
SSH1 iso2 (human) WRQQTDSSLQQPVDD S465
SSH1 iso4 (human) WRQQTDSSLQQPVDD S153
SSH1 (mouse) gap -
SSH1 (rat) gap -
S515-p
PCCFRRLsDPLLPsP
Upstream
0 15
Treatment
  • metastatic potential
  • metformin
SSH1 (human) PCCFRRLsDPLLPsP S515-p
SSH1 iso2 (human) PCCFRRLSDPLLPSP S515
SSH1 iso4 (human) PCCFRRLSDPLLPSP S203
SSH1 (mouse) PCCFRRLsDPLLLPH S516-p
SSH1 (rat) PCCFRRLsDPLLLPH S508-p
S521-p
LsDPLLPsPEDEtGS
Upstream
0 4
Treatment
  • metformin
SSH1 (human) LsDPLLPsPEDEtGS S521-p
SSH1 iso2 (human) LSDPLLPSPEDETGS S521
SSH1 iso4 (human) LSDPLLPSPEDETGS S209
SSH1 (mouse) LsDPLLLPHHDETGG P522
SSH1 (rat) LsDPLLLPHRDGAGG P514
T526-p
LPsPEDEtGSLVHLE
0 1
SSH1 (human) LPsPEDEtGSLVHLE T526-p
SSH1 iso2 (human) LPSPEDETGSLVHLE T526
SSH1 iso4 (human) LPSPEDETGSLVHLE T214
SSH1 (mouse) LLPHHDETGGLVHLE T527
SSH1 (rat) LLPHRDGAGGLVHLE A519
S576-p
KKKLEFGsPKGRSGs
Upstream
0 15
Regulatory protein:
  • CD38 (human)
Treatment
  • nocodazole
SSH1 (human) KKKLEFGsPKGRSGs S576-p
SSH1 iso2 (human) KKKLEFGSPKGRSGS S576
SSH1 iso4 (human) KKKLEFGSPKGRSGS S264
SSH1 (mouse) KRKLEFGNsKPRSDs N578
SSH1 (rat) KRKLEFGsPKARSGS S569-p
P577
KKLEFGsPKGRSGsL
0 1
SSH1 (human) KKLEFGsPKGRSGsL P577
SSH1 iso2 (human) KKLEFGSPKGRSGSL P577
SSH1 iso4 (human) KKLEFGSPKGRSGSL P265
SSH1 (mouse) RKLEFGNsKPRSDsL S579-p
SSH1 (rat) RKLEFGsPKARSGSL P570
S583-p
sPKGRSGsLLQVEEt
0 8
SSH1 (human) sPKGRSGsLLQVEEt S583-p
SSH1 iso2 (human) SPKGRSGSLLQVEET S583
SSH1 iso4 (human) SPKGRSGSLLQVEET S271
SSH1 (mouse) NsKPRSDsLPQVEEL S585-p
SSH1 (rat) sPKARSGSLPQVEEL S576
T590-p
sLLQVEEtEREEGLG
0 1
SSH1 (human) sLLQVEEtEREEGLG T590-p
SSH1 iso2 (human) SLLQVEETEREEGLG T590
SSH1 iso4 (human) SLLQVEETEREEGLG T278
SSH1 (mouse) sLPQVEELEKDGsPR L592
SSH1 (rat) SLPQVEELEKDGsPR L583
G595
EEtEREEGLGAGRWG
0 4
SSH1 (human) EEtEREEGLGAGRWG G595
SSH1 iso2 (human) EETEREEGLGAGRWG G595
SSH1 iso4 (human) EETEREEGLGAGRWG G283
SSH1 (mouse) EELEKDGsPRTGRWR S597-p
SSH1 (rat) EELEKDGsPRPGRWR S588-p
P605
AGRWGQLPTQLDQNL
0 45
SSH1 (human) AGRWGQLPTQLDQNL P605
SSH1 iso2 (human) AGRWGQLPTQLDQNL P605
SSH1 iso4 (human) AGRWGQLPTQLDQNL P293
SSH1 (mouse) TGRWRRAstQLDRsL S607-p
SSH1 (rat) PGRWRRAstQLERGL S598-p
T606
GRWGQLPTQLDQNLL
0 3
SSH1 (human) GRWGQLPTQLDQNLL T606
SSH1 iso2 (human) GRWGQLPTQLDQNLL T606
SSH1 iso4 (human) GRWGQLPTQLDQNLL T294
SSH1 (mouse) GRWRRAstQLDRsLL T608-p
SSH1 (rat) GRWRRAstQLERGLL T599-p
N611
LPTQLDQNLLNSENL
0 2
SSH1 (human) LPTQLDQNLLNSENL N611
SSH1 iso2 (human) LPTQLDQNLLNSENL N611
SSH1 iso4 (human) LPTQLDQNLLNSENL N299
SSH1 (mouse) AstQLDRsLLDQENL S613-p
SSH1 (rat) AstQLERGLLDQENL G604
-
gap
0 1
SSH1 (human) gap -
SSH1 iso2 (human) PAGWHTPsLPSHSNW S644-p
SSH1 iso4 (human) gap -
SSH1 (mouse) gap -
SSH1 (rat) gap -
S645-p
ILNKVKPsyKSCADC
0 1
SSH1 (human) ILNKVKPsyKSCADC S645-p
SSH1 iso2 (human) gap -
SSH1 iso4 (human) ILNKVKPSYKSCADC S333
SSH1 (mouse) ILSKVKPPYtSCADC P648
SSH1 (rat) ILSKVKPPYTSCADC P639
Y646-p
LNKVKPsyKSCADCM
0 1
SSH1 (human) LNKVKPsyKSCADCM Y646-p
SSH1 iso2 (human) gap -
SSH1 iso4 (human) LNKVKPSYKSCADCM Y334
SSH1 (mouse) LSKVKPPYtSCADCM Y649
SSH1 (rat) LSKVKPPYTSCADCM Y640
K647
NKVKPsyKSCADCMY
0 1
SSH1 (human) NKVKPsyKSCADCMY K647
SSH1 iso2 (human) gap -
SSH1 iso4 (human) NKVKPSYKSCADCMY K335
SSH1 (mouse) SKVKPPYtSCADCMY T650-p
SSH1 (rat) SKVKPPYTSCADCMY T641
K758-m1
LPKSLLLkNSHCDKN
0 1
SSH1 (human) LPKSLLLkNSHCDKN K758-m1
SSH1 iso2 (human) gap -
SSH1 iso4 (human) LPKSLLLKNSHCDKN K446
SSH1 (mouse) LPKSLQLKNPHCDKN K761
SSH1 (rat) LQKSLLSKNSHCDKN K751
S812-p
YLMQHQEsIIQLQKA
0 1
SSH1 (human) YLMQHQEsIIQLQKA S812-p
SSH1 iso2 (human) gap -
SSH1 iso4 (human) YLMQHQESIIQLQKA S500
SSH1 (mouse) YLMQHQESIIQLQKA S815
SSH1 (rat) YLMQHQESIIQLQKA S805
T826-p
AGLVRKHtKELERLK
Upstream
Downstream
1 0
Effects on Modified Protein
  • phosphorylation
Kinase, in vitro:
  • Akt1 (human)
Putative in vivo kinases:
  • Akt1 (human)
Treatment
  • Akt_inhibitor_VIII
SSH1 (human) AGLVRKHtKELERLK T826-p
SSH1 iso2 (human) gap -
SSH1 iso4 (human) AGLVRKHTKELERLK T514
SSH1 (mouse) AGLVRKHTKELERLK T829
SSH1 (rat) AGLVRKHTKELERLK T819
S834-p
KELERLKsVPADPAP
Upstream
Downstream
1 6
Effects on Modified Protein
  • enzymatic activity, inhibited
  • molecular association, regulation
Phosphatases, in vitro:
  • SSH1 (human)
Putative upstream phosphatases:
  • SSH1 (human)
Regulatory protein:
  • NOX1 (rat)
Treatment
  • PDGF
SSH1 (human) KELERLKsVPADPAP S834-p
SSH1 iso2 (human) gap -
SSH1 iso4 (human) KELERLKSVPADPAP S522
SSH1 (mouse) KELERLKSLPSDSPA S837
SSH1 (rat) KELERLKSLPSDSPS S827
S854-p
PASRLEAsIPEESQD
0 3
SSH1 (human) PASRLEAsIPEESQD S854-p
SSH1 iso2 (human) gap -
SSH1 iso4 (human) PASRLEASIPEESQD S542
SSH1 (mouse) ATCRLEASIPEEGSQ S857
SSH1 (rat) AASRLEASIPEEGQE S847
S889-p
KSEAAPAsLEGGsLK
Upstream
0 3
Treatment
  • selumetinib
  • vemurafenib
SSH1 (human) KSEAAPAsLEGGsLK S889-p
SSH1 iso2 (human) gap -
SSH1 iso4 (human) KSEAAPASLEGGSLK S577
SSH1 (mouse) gap -
SSH1 (rat) gap -
S894-p
PAsLEGGsLKsPPPF
0 2
SSH1 (human) PAsLEGGsLKsPPPF S894-p
SSH1 iso2 (human) gap -
SSH1 iso4 (human) PASLEGGSLKSPPPF S582
SSH1 (mouse) EEQPVGGTLQKsPtS T885
SSH1 (rat) EEKPVGGASQKsPPP A874
S897-p
LEGGsLKsPPPFFYR
Upstream
0 12
Regulatory protein:
  • CD38 (human)
SSH1 (human) LEGGsLKsPPPFFYR S897-p
SSH1 iso2 (human) gap -
SSH1 iso4 (human) LEGGSLKSPPPFFYR S585
SSH1 (mouse) VGGTLQKsPtSTLPR S889-p
SSH1 (rat) VGGASQKsPPPTLLL S878-p
P899
GGsLKsPPPFFYRLD
0 1
SSH1 (human) GGsLKsPPPFFYRLD P899
SSH1 iso2 (human) gap -
SSH1 iso4 (human) GGSLKSPPPFFYRLD P587
SSH1 (mouse) GTLQKsPtSTLPRLD T891-p
SSH1 (rat) GASQKsPPPTLLLRL P880
T908-p
FFYRLDHtSsFSKDF
Upstream
0 2
Treatment
  • BI2536
SSH1 (human) FFYRLDHtSsFSKDF T908-p
SSH1 iso2 (human) gap -
SSH1 iso4 (human) FFYRLDHTSSFSKDF T596
SSH1 (mouse) TLPRLDHTSNFSKDF T900
SSH1 (rat) LLLRLDHTSKDFSKD T890
S910-p
YRLDHtSsFSKDFLK
0 2
SSH1 (human) YRLDHtSsFSKDFLK S910-p
SSH1 iso2 (human) gap -
SSH1 iso4 (human) YRLDHTSSFSKDFLK S598
SSH1 (mouse) PRLDHTSNFSKDFLK N902
SSH1 (rat) RLDHTSKDFSKDFLK D893
T922-p
FLKTICYtPTSSSMS
0 2
SSH1 (human) FLKTICYtPTSSSMS T922-p
SSH1 iso2 (human) gap -
SSH1 iso4 (human) FLKTICYTPTSSSMS T610
SSH1 (mouse) FLKTVCYTPTSSSIS T914
SSH1 (rat) FLKSACYTPTPSSIS T905
T933-p
SSMSSNLtRssssDs
0 1
SSH1 (human) SSMSSNLtRssssDs T933-p
SSH1 iso2 (human) gap -
SSH1 iso4 (human) SSMSSNLTRSSSSDS T621
SSH1 (mouse) SSISSNLTRsssSDs T925
SSH1 (rat) SSISSNLTRSSsSDS T916
S935-p
MSSNLtRssssDsIH
0 6
SSH1 (human) MSSNLtRssssDsIH S935-p
SSH1 iso2 (human) gap -
SSH1 iso4 (human) MSSNLTRSSSSDSIH S623
SSH1 (mouse) ISSNLTRsssSDsIH S927-p
SSH1 (rat) ISSNLTRSSsSDSIH S918
S936-p
SSNLtRssssDsIHs
0 11
SSH1 (human) SSNLtRssssDsIHs S936-p
SSH1 iso2 (human) gap -
SSH1 iso4 (human) SSNLTRSSSSDSIHS S624
SSH1 (mouse) SSNLTRsssSDsIHs S928-p
SSH1 (rat) SSNLTRSSsSDSIHS S919
S937-p
SNLtRssssDsIHsV
Upstream
Downstream
3 39
Effects on Modified Protein
  • activity, inhibited
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • cell motility, altered
Kinase, in vitro:
  • PRKD1 (human)
Putative in vivo kinases:
  • PRKD1 (human)
  • PRKD2 (human)
Treatment
  • EGF
  • metastatic potential
  • metformin
  • SII_angiotensin_2
view more >
SSH1 (human) SNLtRssssDsIHsV S937-p
SSH1 iso2 (human) gap -
SSH1 iso4 (human) SNLTRSSSSDSIHSV S625
SSH1 (mouse) SNLTRsssSDsIHsV S929-p
SSH1 (rat) SNLTRSSsSDSIHSV S920-p
S938-p
NLtRssssDsIHsVR
0 1
SSH1 (human) NLtRssssDsIHsVR S938-p
SSH1 iso2 (human) gap -
SSH1 iso4 (human) NLTRSSSSDSIHSVR S626
SSH1 (mouse) NLTRsssSDsIHsVR S930
SSH1 (rat) NLTRSSsSDSIHSVR S921
S940-p
tRssssDsIHsVRGK
Upstream
0 3
Treatment
  • SII_angiotensin_2
SSH1 (human) tRssssDsIHsVRGK S940-p
SSH1 iso2 (human) gap -
SSH1 iso4 (human) TRSSSSDSIHSVRGK S628
SSH1 (mouse) TRsssSDsIHsVRGK S932-p
SSH1 (rat) TRSSsSDSIHSVRGK S923
S943-p
sssDsIHsVRGKPGL
0 1
SSH1 (human) sssDsIHsVRGKPGL S943-p
SSH1 iso2 (human) gap -
SSH1 iso4 (human) SSSDSIHSVRGKPGL S631
SSH1 (mouse) ssSDsIHsVRGKPGL S935-p
SSH1 (rat) SsSDSIHSVRGKPGL S926
K952-ac
RGKPGLVkQRTQEIE
0 1
SSH1 (human) RGKPGLVkQRTQEIE K952-ac
SSH1 iso2 (human) gap -
SSH1 iso4 (human) RGKPGLVKQRTQEIE K640
SSH1 (mouse) RGKPGLVKQRAQEIE K944
SSH1 (rat) RGKPGLVKQRAQEIE K935
S970-p
RLAGLTVssPLKRSH
0 1
SSH1 (human) RLAGLTVssPLKRSH S970-p
SSH1 iso2 (human) gap -
SSH1 iso4 (human) RLAGLTVSSPLKRSH S658
SSH1 (mouse) RLAGLTVSSPLKRSH S962
SSH1 (rat) RLAGLTVSSPLKRSH S953
S971-p
LAGLTVssPLKRSHs
0 4
SSH1 (human) LAGLTVssPLKRSHs S971-p
SSH1 iso2 (human) gap -
SSH1 iso4 (human) LAGLTVSSPLKRSHS S659
SSH1 (mouse) LAGLTVSSPLKRSHs S963
SSH1 (rat) LAGLTVSSPLKRSHS S954
S978-p
sPLKRSHsLAKLGSL
Upstream
Downstream
9 1
Effects on Modified Protein
  • activity, inhibited
  • intracellular localization
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • cell motility, altered
Kinase, in vitro:
  • PRKD1 (human)
Putative in vivo kinases:
  • PRKD1 (human)
  • PRKD2 (human)
Regulatory protein:
  • CAP1 (human)
  • PKD2 (human)
  • PRKD3 (human)
  • PTEN (human)
  • RHOA (human)
view more >
Treatment
  • Freund's_complete_adjuvant
  • H2O2
  • neuregulin
  • siRNA
view more >
SSH1 (human) sPLKRSHsLAKLGSL S978-p
SSH1 iso2 (human) gap -
SSH1 iso4 (human) SPLKRSHSLAKLGSL S666
SSH1 (mouse) SPLKRSHsLAKLGsL S970-p
SSH1 (rat) SPLKRSHSLAKLGSL S961
S984
HsLAKLGSLTFSTED
1 0
SSH1 (human) HsLAKLGSLTFSTED S984
SSH1 iso2 (human) gap -
SSH1 iso4 (human) HSLAKLGSLTFSTED S672
SSH1 (mouse) HsLAKLGsLNFSTED S976-p
SSH1 (rat) HSLAKLGSLNFSTED S967
T1021-p
FLHEPQGtPRDPAAT
0 2
SSH1 (human) FLHEPQGtPRDPAAT T1021-p
SSH1 iso2 (human) gap -
SSH1 iso4 (human) FLHEPQGTPRDPAAT T709
SSH1 (mouse) FLPEPQSAPRDPAAT A1014
SSH1 (rat) FLPEPQAAPRNPSAT A1004
K1041-m1
KPAPENLksPSWMSK
0 1
SSH1 (human) KPAPENLksPSWMSK K1041-m1
SSH1 iso2 (human) gap -
SSH1 iso4 (human) KPAPENLKSPSWMSK K729
SSH1 (mouse) KSAPEHLKSPSRVNK K1034
SSH1 (rat) KSAPENLKIPVRVNK K1024
S1042-p
PAPENLksPSWMSKS
0 5
SSH1 (human) PAPENLksPSWMSKS S1042-p
SSH1 iso2 (human) gap -
SSH1 iso4 (human) PAPENLKSPSWMSKS S730
SSH1 (mouse) SAPEHLKSPSRVNKS S1035
SSH1 (rat) SAPENLKIPVRVNKS I1025